Table 3.
Test statistics: intention-to-treat (ITT) and completer analyses comparing intervention group (ITT, completers) and wait-list control group.
| Outcomes | T0a | T1b | ||||||||
| ITTc | Completer | ITT | Completer | |||||||
| t67 | P | t44 | P | F1,66 | P | d | F1,43 | P | d | |
| Emotion Regulation Skills Questionnaire (ERSQ) | 0.42 | .67 | 1.50 | .14 | 3.89 | .05 | 0.49 | 4.98 | .03 | 0.68 |
| Patient Health Questionnaire-9 (PHQ-9) | 0.11 | .92 | 1.10 | .28 | 6.01 | .02 | 0.60 | 19.01 | <.001 | 1.33 |
| Generalized Anxiety Disorder Assessment (GAD-7) | 0.07 | .95 | 0.68 | .50 | 0.02 | .88 | 0.00 | 4.09 | .049 | 0.62 |
| European Health Interview Survey Quality of Life 8 (EUROHIS-QOL-8) | 0.38 | .70 | 2.12 | .04 | 4.63 | .04 | 0.53 | 7.35 | .01 | 0.83 |
| Rosenberg Self-Esteem Scale (RSE) | 0.96 | .34 | 1.01 | .32 | 0.81 | .37 | 0.22 | 0.12 | .73 | 0.11 |
| Somatic Symptom Scale (SSS-8) | 0.23 | .82 | 1.41 | .17 | 2.41 | .01 | 0.38 | 1.51 | .23 | 0.38 |
| Cambridge Depersonalization Scale Short Version (CDS-2) | 2.33 | .02 | 2.63 | .01 | 0.70 | .41 | 0.21 | 2.03 | .08 | 0.55 |
| Subjective prognosis of gainful employment (SPE) | 0.71 | .48 | 1.23 | .23 | 0.15 | .70 | 0.09 | 1.60 | .21 | 0.39 |
aT0: baseline; t test with test statistics (tdf), level of significance (P).
bT1: End of intervention; analysis of covariance with F test statistics (Fdf), level of significance (P) and effect size (Cohen d).
cITT: Intention-to-treat.